New hope for tough lung cancer: drug targets rare transformation
NCT ID NCT07414927
First seen Feb 18, 2026 · Last updated May 23, 2026 · Updated 15 times
Summary
This study tests a new drug, BL0020, in 48 people whose lung cancer changed from one type to a more aggressive small cell form after initial treatment. The goal is to see if the drug can shrink tumors and control the disease. Participants must have this specific cancer transformation and meet other health criteria.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL CARCINOMA OF LUNG are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Chest Hospital
Shanghai, 200030, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.